CABT-BL1761

antibody from Creative Diagnostics
Targeting: HCAR2 GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG
Provider product page for CABT-BL1761
Western blot
Immunocytochemistry

Antibody data

Product number
CABT-BL1761 - Provider product page
Provider
Creative Diagnostics
Product name
Anti-HCAR2 (aa 250-350) polyclonal antibody
Antibody type
Polyclonal
Description
Acts as a high affinity receptor for both nicotinic acid (also known as niacin) and (D)-beta-hydroxybutyrate and mediates increased adiponectin secretion and decreased lipolysis through G(i)-protein-mediated inhibition of adenylyl cyclase. This pharmacological effect requires nicotinic acid doses that are much higher than those provided by a normal diet. Mediates nicotinic acid-induced apoptosis in mature neutrophils. Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. The rank order of potency for the displacement of nicotinic acid binding is 5-methyl pyrazole-3-carboxylic acid = pyridine-3-acetic acid> acifran> 5-methyl nicotinic acid = acipimox>> nicotinuric acid = nicotinamide.
Reactivity
Human
Host
Rabbit
Conjugate
Unconjugated
Isotype
IgG
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
HCAR2 protein structure - CABT-BL1761 shown in red.